Insempra
Insempra is a biotechnology-powered company enabling businesses to transform their ingredient lists with superior products made in collaboration with nature. For too long, businesses have relied on petrochemical production and environmental exploitation, depleting our limited natural resources and polluting our planet.
$20M
Latest Funding
Series A
Latest Funding Stage
2024-05-08
Funding Date
39
Employees
Germany
Location
Planegg, Bayern
City & State
Sales-Ready Summary
Insempra recently secured $20M in Series A funding and is hiring for Biotechnology and Fermentation Science roles, signaling potential expansion in their R&D and production capabilities.
Key Contacts
Open Positions
View Careers PageHiring For
Similar Startups
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that focuses on developing innovative technologies for drug discovery. The company utilizes advanced live-cell resolution microscopy and engineering to identify and create new therapeutic candidates. Eikon Therapeutics aims to enhance the understanding of biological processes at a cellular level,supporting targeted treatment development.
Arsenale Bioyards
Arsenale is transforming biomanufacturing with a proprietary end-to-end platform that integrates advanced hardware, AI-driven software, and precision fermentation. Designed to bridge the gap from lab-scale innovation to industrial-scale production, Arsenale enables industries like food, chemicals, and materials to seamlessly develop and scalebio-based alternatives to petrochemicals and animal-derived products.
Claros
Claros is a power management platform provider that utilizes cutting-edge hardware and software to enhance energy distribution and usage at data centers, thereby boosting compute performance and maximizing efficiency.
Avitia
Avitia improves cancer treatment via advanced molecular testing solutions. Avitia offer testing tools for use on-site, bioinformatics driven by AI, and actionable insights aimed at enhancing patient outcomes. Avitia offerings comprise pre-prepared NGS panels, simplified reporting mechanisms, and cooperative diagnostic platforms.